• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
GUO Anping, JIANG Fen, XU Xiaoli, YOU Qidong, LI Yuyan. Design, synthesis and biological application of affinity-based small molecular probe for Hsp90 endoplasmic reticulum paralogue of Grp94[J]. Journal of China Pharmaceutical University, 2019, 50(2): 161-167. DOI: 10.11665/j.issn.1000-5048.20190205
Citation: GUO Anping, JIANG Fen, XU Xiaoli, YOU Qidong, LI Yuyan. Design, synthesis and biological application of affinity-based small molecular probe for Hsp90 endoplasmic reticulum paralogue of Grp94[J]. Journal of China Pharmaceutical University, 2019, 50(2): 161-167. DOI: 10.11665/j.issn.1000-5048.20190205

Design, synthesis and biological application of affinity-based small molecular probe for Hsp90 endoplasmic reticulum paralogue of Grp94

More Information
  • Glucose-regulated protein 94(Grp94), an endoplasmic reticulum resident Hsp90 paralog, has a limited set of client proteins. Selective inhibition of Grp94 has emerged as a new direction for the development of drugs targeting the Hsp90 chaperone system. Now Grp94-Probe, an affinity-based probe of Grp94, was designed and synthesized based on DDO-5813, a most potent Grp94-selective inhibitor we found previously. Using fluorescence polarization(FP)assay and double staining assay with ER-Red in cells, we confirmed the binding of Grp94-Probe with ER Grp94. The FR results showed that the probe exhibited high affinity for Grp94N(EC50=117. 9 nmol/L)without exhibiting obvious Hsp90α inhibition, Moreover, as a fluorescence probe molecule, Grp94-Probe could better distinguish the inhibitory activity of compounds for Grp94N. The results of fluorescence analysis in cells showed that Grp94-Probe could co-stain with ER-Red in the endoplasmic reticulum, and the fluorescence did not decay rapidly with time after 4 h of staining, which further indicated the binding of Grp94-Probe with Grp94 in cells. This Grp94 selective probe can be further used for biology evaluation of Grp94 inhibitor and exploration of Grp94 biological functions.
  • [1]
    Liu F,Sun HP,You QD.Advances in small-molecule inhibitors targeting Hsp90-Cdc37 protein-protein interaction[J].J China Pharm Univ(中国药科大学学报),2015,46(3):272-278.
    [2]
    Hetz C, Papa FR. The unfolded protein response and cell fate control[J].Mol Cell,2017,69(2):169-181.
    [3]
    Zheng HC, Takahashi H, Takano Y, et al. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas[J].Hum Pathol,2008,39(7):1042-1049.
    [4]
    Xu Y,Chen Z,Li X,et al.HSP90B1 overexpression predicts poor prognosis in NSCLC patients[J].Tumour Biol,2016,37(10):14321-14328.
    [5]
    Staron M,Yang Y,Li Z,et al.Gp96,an endoplasmic reticulum master chaperone for integrins and Toll-like receptors,selectively regulates early T and B lymphopoiesis[J].Blood,2010,115(12):2380-2390.
    [6]
    Liu B,Staron M,Li Z,et al.Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway[J].Proc Natl Acad Sci U S A,2013,110(17):6877-6882.
    [7]
    Wanderling S,Simen BB,Argon Y,et al.Grp94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion[J].Mol Biol Cell,2007,18(10):3764-3775.
    [8]
    Zhang Y,Wu BX,Li Z,et al.GP96 is a GARP chaperone and controls regulatory T cell functions[J].J Clin Invest,2015,125(2):859-869.
    [9]
    Staron M,Wu S,Li Z,et al.Heat-shock protein gp96/grp94 is an essential chaperone for the platelet glycoprotein Ib-IX-V complex[J].Blood,2011,117(26):7136-7144.
    [10]
    Patel PD,Yan P,Chiosis G,et al.Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2[J].Nat Chem Biol,2013,9(11):677-684.
    [11]
    Gewirth DT. Paralog specific Hsp90 inhibitors a brief history and a bright future[J].Curr Top Med Chem,2016,16(25):2779-2791.
    [12]
    Taldone T,Patel PD,Chiosis G,et al.Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series[J].J Med Chem,2013,56(17):6803-6818.
    [13]
    Jiang F, Guo AP, You QD, et al. Discovery of a potent Grp94 selective inhibitor with anti-inflammatory efficacy in a mouse model of ulcerative colitis[J].J Med Chem,2018,61(21):9513-9533.
  • Related Articles

    [1]LI Zhiyan, LI Xianghui, AI Shichao, YIN Yi, LIU Song, GUAN Wenxian. Application of nanomedicines targeting non-glucose nutrients in tumor starvation therapy[J]. Journal of China Pharmaceutical University, 2022, 53(4): 392-399. DOI: 10.11665/j.issn.1000-5048.20220402
    [2]PAN Xiuhua, WU Zhenghong, QI Xiaole. Research status and application progress of CRISPR/Cas9 delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(1): 10-18. DOI: 10.11665/j.issn.1000-5048.20200102
    [3]JI Liyang, HAO Jing, WANG Guocheng, XIE Weijia. Research progress on stimulator of interferon genes agonists for cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2020, 51(1): 1-9. DOI: 10.11665/j.issn.1000-5048.20200101
    [4]SUN Xiaofeng, LIU Tao, LING Yun, CHEN Zhengwei, PAN Zihao, XU Zite, LUO Ling. Advances in research of hyaluronic acid modified nanomicelles for targeting tumor therapy and drug release behavior[J]. Journal of China Pharmaceutical University, 2019, 50(6): 641-647. DOI: 10.11665/j.issn.1000-5048.20190602
    [5]XU Xiangting, WANG Wei. Advances of functionalized carbon nanotubes in diagnosis and treatment of tumor[J]. Journal of China Pharmaceutical University, 2018, 49(2): 165-172. DOI: 10.11665/j.issn.1000-5048.20180205
    [6]CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103
    [7]ZHANG Ran, TIAN Hong, GAO Xiangdong, YAO Wenbing. Application of next generation genome editing technology in gene therapy and biopharmaceuticals[J]. Journal of China Pharmaceutical University, 2014, 45(4): 504-510. DOI: 10.11665/j.issn.1000-5048.20140421
    [8]JIANG Hulin. Biocompatible polymers for gene delivery in cancer gene therapy[J]. Journal of China Pharmaceutical University, 2013, 44(5): 476-481. DOI: 10.11665/j.issn.1000-5048.20130518
    [9]YAO Jing, FAN Ying, ZHOU Jian-ping, LI Fei-yan. Advances on the study of new cationic polymers as gene vectors[J]. Journal of China Pharmaceutical University, 2011, 42(2): 176-181.
    [10]Pharmacokinetics of Magnetic Nanoparticles as Drug Carrier and Their Applications in Cancer Diagnosis and Therapy[J]. Journal of China Pharmaceutical University, 2003, (3): 85-88.

Catalog

    Article views (1062) PDF downloads (1110) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return